| 10793894 |
Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2020-10-06 |
| 10683530 |
Detection of oligosaccharides |
Jillian R. Brown, Charles A. Glass |
2020-06-16 |
| 10677786 |
Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2020-06-09 |
| 10260084 |
Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2019-04-16 |
| 9915649 |
Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2018-03-13 |
| 9796999 |
Detection of oligosaccharides |
Jillian R. Brown, Charles A. Glass |
2017-10-24 |
| 9677116 |
Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2017-06-13 |
| 9340822 |
Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2016-05-17 |
| 9222120 |
Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition |
Jilllian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2015-12-29 |
| 9029530 |
Detection of oligosaccharides |
Jillian R. Brown, Charles A. Glass |
2015-05-12 |
| 8809009 |
Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2014-08-19 |
| 8771974 |
Methods of determining the presence and/or amount of a biomarker to determine the presence, identity, and/or severity of a lysosomal storage or neurological disorder |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2014-07-08 |
| 8592140 |
Detection of oligosaccharides |
Jillian R. Brown, Charles A. Glass |
2013-11-26 |
| 8232073 |
Quantification of non-reducing end glycan residual compounds |
Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman |
2012-07-31 |
| 8183003 |
Polymer end group detection |
Jillian R. Brown, Charles A. Glass |
2012-05-22 |